GW Pharma Ltd
Desconocido
NEUROPAIN: Neuropathic pain biomarkers and druggable targets within the endogenous analgesia system
GW PHARMA LIMITED
participó en un
FP7:
Neuropathic pain has a high incidence in Europe and often affects the patient’s emotional balance and quality of life. Recent meta-analyses...
Financiado
Financiado
* No se disponen de datos de la empresa actual.